# Non-small Cell Lung Cancer Study US75 (Z-PACT)

> **NCT00086268** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 250 (actual)

## Conditions studied

- Non Small Cell Lung Carcinoma

## Interventions

- **DRUG:** zoledronic acid
- **DRUG:** Taxotere
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00086268
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2017-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086268, "Non-small Cell Lung Cancer Study US75 (Z-PACT)". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT00086268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*